View Future GrowthIndian Phosphate 過去の業績過去 基準チェック /56Indian Phosphateは、平均年間9.5%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間6.2% 14.6%収益成長率で 成長しています。 Indian Phosphateの自己資本利益率は12.5%であり、純利益率は2%です。主要情報9.49%収益成長率1.96%EPS成長率Chemicals 業界の成長17.68%収益成長率14.64%株主資本利益率12.47%ネット・マージン2.04%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • Jun 03Full year 2026 earnings released: EPS: ₹8.78 (vs ₹3.92 in FY 2025)Full year 2026 results: EPS: ₹8.78 (up from ₹3.92 in FY 2025). Revenue: ₹10.7b (up 21% from FY 2025). Net income: ₹219.3m (up 153% from FY 2025). Profit margin: 2.0% (up from 1.0% in FY 2025). The increase in margin was driven by higher revenue.分析記事 • Nov 23Indian Phosphate's (NSE:IPHL) Shareholders May Want To Dig Deeper Than Statutory ProfitIndian Phosphate Limited ( NSE:IPHL ) just released a solid earnings report, and the stock displayed some strength...お知らせ • Nov 14Indian Phosphate Limited to Report First Half, 2026 Results on Nov 14, 2025Indian Phosphate Limited announced that they will report first half, 2026 results on Nov 14, 2025Reported Earnings • Sep 08Full year 2025 earnings released: EPS: ₹3.92 (vs ₹7.21 in FY 2024)Full year 2025 results: EPS: ₹3.92 (down from ₹7.21 in FY 2024). Revenue: ₹8.86b (up 24% from FY 2024). Net income: ₹86.9m (down 34% from FY 2024). Profit margin: 1.0% (down from 1.8% in FY 2024). The decrease in margin was driven by higher expenses.すべての更新を表示Recent updatesReported Earnings • Jun 03Full year 2026 earnings released: EPS: ₹8.78 (vs ₹3.92 in FY 2025)Full year 2026 results: EPS: ₹8.78 (up from ₹3.92 in FY 2025). Revenue: ₹10.7b (up 21% from FY 2025). Net income: ₹219.3m (up 153% from FY 2025). Profit margin: 2.0% (up from 1.0% in FY 2025). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹63.95, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 8.6% over the past year.Valuation Update With 7 Day Price Move • Mar 10Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹61.55, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 15% over the past year.分析記事 • Feb 10Some Investors May Be Worried About Indian Phosphate's (NSE:IPHL) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹61.90, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 10% over the past year.分析記事 • Nov 23Indian Phosphate's (NSE:IPHL) Shareholders May Want To Dig Deeper Than Statutory ProfitIndian Phosphate Limited ( NSE:IPHL ) just released a solid earnings report, and the stock displayed some strength...New Risk • Nov 18New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 29% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹1.47b market cap, or US$16.6m).分析記事 • Nov 15There Is A Reason Indian Phosphate Limited's (NSE:IPHL) Price Is UndemandingIndian Phosphate Limited's ( NSE:IPHL ) price-to-earnings (or "P/E") ratio of 18.1x might make it look like a buy right...New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (₹1.57b market cap, or US$17.7m).お知らせ • Nov 14Indian Phosphate Limited to Report First Half, 2026 Results on Nov 14, 2025Indian Phosphate Limited announced that they will report first half, 2026 results on Nov 14, 2025Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹62.90, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 33% over the past year.お知らせ • Sep 08Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025, at 11:30 Indian Standard Time.Reported Earnings • Sep 08Full year 2025 earnings released: EPS: ₹3.92 (vs ₹7.21 in FY 2024)Full year 2025 results: EPS: ₹3.92 (down from ₹7.21 in FY 2024). Revenue: ₹8.86b (up 24% from FY 2024). Net income: ₹86.9m (down 34% from FY 2024). Profit margin: 1.0% (down from 1.8% in FY 2024). The decrease in margin was driven by higher expenses.New Risk • Sep 04New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended March 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2024 fiscal period end). Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.35b market cap, or US$15.4m).Board Change • Aug 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • May 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹52.25, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India.New Risk • Apr 01New major risk - Revenue and earnings growthRevenue has declined by 7.0% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.13b market cap, or US$13.2m).New Risk • Mar 22New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.21b market cap, or US$14.1m).Board Change • Mar 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.分析記事 • Mar 04Indian Phosphate Limited (NSE:IPHL) Stock's 29% Dive Might Signal An Opportunity But It Requires Some ScrutinyTo the annoyance of some shareholders, Indian Phosphate Limited ( NSE:IPHL ) shares are down a considerable 29% in the...Board Change • Nov 19High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Sep 19Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹115, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 36x in the Chemicals industry in India.Board Change • Sep 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.収支内訳Indian Phosphate の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NSEI:IPHL 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費31 Mar 2610,734219139031 Dec 2510,141178142030 Sep 259,548137146030 Jun 259,194112141031 Mar 258,84087136031 Mar 247,14913172031 Mar 237,68716570031 Mar 225,57216265031 Mar 214,1455143031 Mar 203,7892028031 Mar 193,2841625031 Mar 181,73510150質の高い収益: IPHLは 高品質の収益 を持っています。利益率の向上: IPHLの現在の純利益率 (2%)は、昨年(1%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: IPHLの収益は過去 5 年間で年間9.5%増加しました。成長の加速: IPHLの過去 1 年間の収益成長率 ( 152.5% ) は、5 年間の平均 ( 年間9.5%を上回っています。収益対業界: IPHLの過去 1 年間の収益成長率 ( 152.5% ) はChemicals業界12.7%を上回りました。株主資本利益率高いROE: IPHLの 自己資本利益率 ( 12.5% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/11 07:15終値2026/06/11 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Indian Phosphate Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Jun 03Full year 2026 earnings released: EPS: ₹8.78 (vs ₹3.92 in FY 2025)Full year 2026 results: EPS: ₹8.78 (up from ₹3.92 in FY 2025). Revenue: ₹10.7b (up 21% from FY 2025). Net income: ₹219.3m (up 153% from FY 2025). Profit margin: 2.0% (up from 1.0% in FY 2025). The increase in margin was driven by higher revenue.
分析記事 • Nov 23Indian Phosphate's (NSE:IPHL) Shareholders May Want To Dig Deeper Than Statutory ProfitIndian Phosphate Limited ( NSE:IPHL ) just released a solid earnings report, and the stock displayed some strength...
お知らせ • Nov 14Indian Phosphate Limited to Report First Half, 2026 Results on Nov 14, 2025Indian Phosphate Limited announced that they will report first half, 2026 results on Nov 14, 2025
Reported Earnings • Sep 08Full year 2025 earnings released: EPS: ₹3.92 (vs ₹7.21 in FY 2024)Full year 2025 results: EPS: ₹3.92 (down from ₹7.21 in FY 2024). Revenue: ₹8.86b (up 24% from FY 2024). Net income: ₹86.9m (down 34% from FY 2024). Profit margin: 1.0% (down from 1.8% in FY 2024). The decrease in margin was driven by higher expenses.
Reported Earnings • Jun 03Full year 2026 earnings released: EPS: ₹8.78 (vs ₹3.92 in FY 2025)Full year 2026 results: EPS: ₹8.78 (up from ₹3.92 in FY 2025). Revenue: ₹10.7b (up 21% from FY 2025). Net income: ₹219.3m (up 153% from FY 2025). Profit margin: 2.0% (up from 1.0% in FY 2025). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹63.95, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 8.6% over the past year.
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹61.55, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 15% over the past year.
分析記事 • Feb 10Some Investors May Be Worried About Indian Phosphate's (NSE:IPHL) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹61.90, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 10% over the past year.
分析記事 • Nov 23Indian Phosphate's (NSE:IPHL) Shareholders May Want To Dig Deeper Than Statutory ProfitIndian Phosphate Limited ( NSE:IPHL ) just released a solid earnings report, and the stock displayed some strength...
New Risk • Nov 18New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 29% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹1.47b market cap, or US$16.6m).
分析記事 • Nov 15There Is A Reason Indian Phosphate Limited's (NSE:IPHL) Price Is UndemandingIndian Phosphate Limited's ( NSE:IPHL ) price-to-earnings (or "P/E") ratio of 18.1x might make it look like a buy right...
New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (₹1.57b market cap, or US$17.7m).
お知らせ • Nov 14Indian Phosphate Limited to Report First Half, 2026 Results on Nov 14, 2025Indian Phosphate Limited announced that they will report first half, 2026 results on Nov 14, 2025
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹62.90, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 33% over the past year.
お知らせ • Sep 08Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025, at 11:30 Indian Standard Time.
Reported Earnings • Sep 08Full year 2025 earnings released: EPS: ₹3.92 (vs ₹7.21 in FY 2024)Full year 2025 results: EPS: ₹3.92 (down from ₹7.21 in FY 2024). Revenue: ₹8.86b (up 24% from FY 2024). Net income: ₹86.9m (down 34% from FY 2024). Profit margin: 1.0% (down from 1.8% in FY 2024). The decrease in margin was driven by higher expenses.
New Risk • Sep 04New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended March 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2024 fiscal period end). Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.35b market cap, or US$15.4m).
Board Change • Aug 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • May 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹52.25, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India.
New Risk • Apr 01New major risk - Revenue and earnings growthRevenue has declined by 7.0% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.13b market cap, or US$13.2m).
New Risk • Mar 22New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.21b market cap, or US$14.1m).
Board Change • Mar 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Mar 04Indian Phosphate Limited (NSE:IPHL) Stock's 29% Dive Might Signal An Opportunity But It Requires Some ScrutinyTo the annoyance of some shareholders, Indian Phosphate Limited ( NSE:IPHL ) shares are down a considerable 29% in the...
Board Change • Nov 19High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Sep 19Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹115, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 36x in the Chemicals industry in India.
Board Change • Sep 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.